# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-26-032950
Filing Date
2026-03-23
Accepted
2026-03-23 06:36:25
Documents
54
Period of Report
2026-03-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm269553d1_8k.htm iXBRL | 8-K | 41951
2 | EXHIBIT 99.1 | tm269553d1_ex99-1.htm | EX-99.1 | 25603
3 | EXHIBIT 99.2 | tm269553d1_ex99-2.htm | EX-99.2 | 76374
7 | GRAPHIC | tm269553d1_ex99-2img001.jpg | GRAPHIC | 96427
8 | GRAPHIC | tm269553d1_ex99-2img002.jpg | GRAPHIC | 384225
9 | GRAPHIC | tm269553d1_ex99-2img003.jpg | GRAPHIC | 138843
10 | GRAPHIC | tm269553d1_ex99-2img004.jpg | GRAPHIC | 78175
11 | GRAPHIC | tm269553d1_ex99-2img005.jpg | GRAPHIC | 205706
12 | GRAPHIC | tm269553d1_ex99-2img006.jpg | GRAPHIC | 205195
13 | GRAPHIC | tm269553d1_ex99-2img007.jpg | GRAPHIC | 111587
14 | GRAPHIC | tm269553d1_ex99-2img008.jpg | GRAPHIC | 89486
15 | GRAPHIC | tm269553d1_ex99-2img009.jpg | GRAPHIC | 144552
16 | GRAPHIC | tm269553d1_ex99-2img010.jpg | GRAPHIC | 130612
17 | GRAPHIC | tm269553d1_ex99-2img011.jpg | GRAPHIC | 141473
18 | GRAPHIC | tm269553d1_ex99-2img012.jpg | GRAPHIC | 125852
19 | GRAPHIC | tm269553d1_ex99-2img013.jpg | GRAPHIC | 72207
20 | GRAPHIC | tm269553d1_ex99-2img014.jpg | GRAPHIC | 120568
21 | GRAPHIC | tm269553d1_ex99-2img015.jpg | GRAPHIC | 130959
22 | GRAPHIC | tm269553d1_ex99-2img016.jpg | GRAPHIC | 134720
23 | GRAPHIC | tm269553d1_ex99-2img017.jpg | GRAPHIC | 139948
24 | GRAPHIC | tm269553d1_ex99-2img018.jpg | GRAPHIC | 64374
25 | GRAPHIC | tm269553d1_ex99-2img019.jpg | GRAPHIC | 121498
26 | GRAPHIC | tm269553d1_ex99-2img020.jpg | GRAPHIC | 153462
27 | GRAPHIC | tm269553d1_ex99-2img021.jpg | GRAPHIC | 376809
28 | GRAPHIC | tm269553d1_ex99-2img022.jpg | GRAPHIC | 132906
29 | GRAPHIC | tm269553d1_ex99-2img023.jpg | GRAPHIC | 132672
30 | GRAPHIC | tm269553d1_ex99-2img024.jpg | GRAPHIC | 132487
31 | GRAPHIC | tm269553d1_ex99-2img025.jpg | GRAPHIC | 130445
32 | GRAPHIC | tm269553d1_ex99-2img026.jpg | GRAPHIC | 109401
33 | GRAPHIC | tm269553d1_ex99-2img027.jpg | GRAPHIC | 171004
34 | GRAPHIC | tm269553d1_ex99-2img028.jpg | GRAPHIC | 99881
35 | GRAPHIC | tm269553d1_ex99-2img029.jpg | GRAPHIC | 82761
36 | GRAPHIC | tm269553d1_ex99-2img030.jpg | GRAPHIC | 149917
37 | GRAPHIC | tm269553d1_ex99-2img031.jpg | GRAPHIC | 191178
38 | GRAPHIC | tm269553d1_ex99-2img032.jpg | GRAPHIC | 103776
39 | GRAPHIC | tm269553d1_ex99-2img033.jpg | GRAPHIC | 143422
40 | GRAPHIC | tm269553d1_ex99-2img034.jpg | GRAPHIC | 169677
41 | GRAPHIC | tm269553d1_ex99-2img035.jpg | GRAPHIC | 93697
42 | GRAPHIC | tm269553d1_ex99-2img036.jpg | GRAPHIC | 152459
43 | GRAPHIC | tm269553d1_ex99-2img037.jpg | GRAPHIC | 115832
44 | GRAPHIC | tm269553d1_ex99-2img038.jpg | GRAPHIC | 250623
45 | GRAPHIC | tm269553d1_ex99-2img039.jpg | GRAPHIC | 227005
46 | GRAPHIC | tm269553d1_ex99-2img040.jpg | GRAPHIC | 136921
47 | GRAPHIC | tm269553d1_ex99-1img001.jpg | GRAPHIC | 3009
| Complete submission text file | 0001104659-26-032950.txt |  | 8446540

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | apge-20260323.xsd | EX-101.SCH | 3044
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | apge-20260323_lab.xml | EX-101.LAB | 34239
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | apge-20260323_pre.xml | EX-101.PRE | 22378
57 | EXTRACTED XBRL INSTANCE DOCUMENT | tm269553d1_8k_htm.xml | XML | 3343

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41740 | Film No.: 26779814
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)